Jonathan S. Wall

4.6k total citations
145 papers, 3.5k citations indexed

About

Jonathan S. Wall is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Jonathan S. Wall has authored 145 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 61 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Physiology. Recurrent topics in Jonathan S. Wall's work include Amyloidosis: Diagnosis, Treatment, Outcomes (85 papers), Medical Imaging Techniques and Applications (26 papers) and Alzheimer's disease research and treatments (25 papers). Jonathan S. Wall is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (85 papers), Medical Imaging Techniques and Applications (26 papers) and Alzheimer's disease research and treatments (25 papers). Jonathan S. Wall collaborates with scholars based in United States, United Kingdom and Sweden. Jonathan S. Wall's co-authors include Alan Solomon, Stephen J. Kennel, Deborah Weiss, Charles L. Murphy, Alan Stuckey, Rudi Hrncic, Maria Schell, Tina Richey, Emily B. Martin and Angela Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Jonathan S. Wall

138 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan S. Wall United States	34	2.6k	844	776	560	346	145	3.5k
Gray D. Shaw United States	29	4.1k 1.6×	315 0.4×	519 0.7×	960 1.7×	500 1.4×	52	8.0k
David R. Booth Australia	41	3.8k 1.5×	1.1k 1.3×	184 0.2×	684 1.2×	399 1.2×	115	6.1k
Dominique Blanchard France	38	1.9k 0.8×	1.2k 1.4×	677 0.9×	990 1.8×	267 0.8×	151	6.6k
Hiroko Iwasaki Japan	39	2.3k 0.9×	308 0.4×	316 0.4×	438 0.8×	528 1.5×	77	3.9k
Kevin L. Moore United States	37	3.3k 1.3×	415 0.5×	921 1.2×	843 1.5×	821 2.4×	59	8.1k
Atsushi Muraguchi Japan	41	2.0k 0.8×	246 0.3×	1.1k 1.5×	1.2k 2.2×	158 0.5×	155	6.6k
Raymond B. Birge United States	47	3.6k 1.4×	973 1.2×	329 0.4×	1.1k 2.0×	1.0k 2.9×	112	7.6k
Amos Baruch United States	30	2.2k 0.8×	175 0.2×	485 0.6×	649 1.2×	377 1.1×	60	3.8k
Margaret A. Lindorfer United States	43	1.8k 0.7×	354 0.4×	1.7k 2.2×	670 1.2×	176 0.5×	103	5.1k
Teruhide Yamaguchi Japan	32	2.2k 0.9×	466 0.6×	318 0.4×	410 0.7×	272 0.8×	108	3.6k

Countries citing papers authored by Jonathan S. Wall

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Wall more than expected).

Fields of papers citing papers by Jonathan S. Wall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Wall. The network helps show where Jonathan S. Wall may publish in the future.

Co-authorship network of co-authors of Jonathan S. Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Wall. A scholar is included among the top collaborators of Jonathan S. Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Wall. Jonathan S. Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stuckey, Alan, et al.. (2025). A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). Journal of Nuclear Cardiology. 56. 102451–102451.

Foster, James S., Sallie Macy, Manasi Balachandran, et al.. (2024). Neutrophils enhance the clearance of systemic amyloid deposits in a murine amyloidoma model. Frontiers in Immunology. 15. 1487250–1487250. 1 indexed citations

Martin, Emily B., et al.. (2023). Longitudinal PET/CT Imaging with Iodine ( 124I) Evuzamitide Reveals Organ Response to Plasma Cell Immunotherapy in a Patient with AL Amyloidosis. Blood. 142(Supplement 1). 6754–6754. 2 indexed citations

Martin, Emily B., Alan Stuckey, Craig Wooliver, et al.. (2023). Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging. Pharmaceuticals. 16(4). 629–629. 21 indexed citations

Wall, Jonathan S., R. Eric Heidel, Emily B. Martin, et al.. (2022). DETECTION OF CARDIAC AMYLOIDOSIS IN PATIENTS WITH SYSTEMIC AL AND ATTR AMYLOIDOSIS USING IODINE EVUZAMITIDE PET/CT IMAGING AND THE CORRELATION WITH SERUM NT-PROBNP. Journal of the American College of Cardiology. 79(9). 1184–1184. 1 indexed citations

Li, Dan L., D. Marshall Brinkley, Emily B. Martin, Jonathan S. Wall, & Rebecca R. Hung. (2021). FALSE NEGATIVE 99MTC-PYROPHOSPHATE SCINTIGRAPHY IN A CASE OF HEREDITARY VARIANT TRANSTHYRETIN (ATTRV) CARDIAC AMYLOIDOSIS. Journal of the American College of Cardiology. 77(18). 2278–2278. 1 indexed citations

Morgan, Gareth J. & Jonathan S. Wall. (2020). The Process of Amyloid Formation due to Monoclonal Immunoglobulins. Hematology/Oncology Clinics of North America. 34(6). 1041–1054. 12 indexed citations

Mapara, Markus Y., Jai Radhakrishnan, Mathew S. Maurer, et al.. (2017). Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis. Blood. 130. 509–509. 18 indexed citations

Blancas‐Mejía, Luis M., Emily B. Martin, Angela Williams, Jonathan S. Wall, & Marina Ramı́rez-Alvarado. (2017). Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients. Biophysical Chemistry. 230. 89–98. 9 indexed citations

10.

Wall, Jonathan S., Angela Williams, Tina Richey, et al.. (2017). Specific Amyloid Binding of Polybasic Peptides In Vivo Is Retained by β-Sheet Conformers but Lost in the Disrupted Coil and All D-Amino Acid Variants. Molecular Imaging and Biology. 19(5). 714–722. 5 indexed citations

11.

Blancas‐Mejía, Luis M., et al.. (2017). Immunoglobulin Light Chains Form an Extensive and Highly Ordered Fibril Involving the N- and C-Termini. ACS Omega. 2(2). 712–720. 18 indexed citations

12.

McLaughlin, Mark F., David J. Robertson, Paul H. Pevsner, et al.. (2013). LnPO ₄ Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy. Cancer Biotherapy and Radiopharmaceuticals. 29(1). 34–41. 38 indexed citations

13.

Wall, Jonathan S., Stephen J. Kennel, Alan Stuckey, et al.. (2010). Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood. 116(13). 2241–2244. 71 indexed citations

14.

Smits, Nicole C., Sindhulakshmi Kurup, Angelique L. Rops, et al.. (2010). The Heparan Sulfate Motif (GlcNS6S-IdoA2S)3, Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease. Journal of Biological Chemistry. 285(52). 41143–41151. 49 indexed citations

15.

LeBlanc, Amy K., Jonathan S. Wall, Federica Morandi, et al.. (2009). NORMAL THORACIC AND ABDOMINAL DISTRIBUTION OF 2‐DEOXY‐2‐[¹⁸F]FLUORO‐d‐GLUCOSE (¹⁸FDG) IN ADULT CATS. Veterinary Radiology & Ultrasound. 50(4). 436–441. 20 indexed citations

16.

Davern, Sandra, Lian X. Tang, Sallie Macy, et al.. (2008). Immunodiagnostic Capabilities of Anti–Free Immunoglobulin Light Chain Monoclonal Antibodies. American Journal of Clinical Pathology. 130(5). 702–711. 21 indexed citations

17.

Legendre, Alfred Μ., et al.. (2007). Cerebral Blastomyces dermatitidis infection in a cat. Journal of the American Veterinary Medical Association. 231(8). 1210–1214. 11 indexed citations

18.

Wall, Jonathan S., Vibha Gupta, Matthew D. Wilkerson, et al.. (2004). Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four V_λ6 proteins. Journal of Molecular Recognition. 17(4). 323–331. 62 indexed citations

19.

Solomon, Alan, Deborah Weiss, & Jonathan S. Wall. (2003). Immunotherapy in Systemic Primary (AL) Amyloidosis Using Amyloid-Reactive Monoclonal Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 18(6). 853–860. 49 indexed citations

20.

Murphy, Charles L., Manfred Eulitz, Rudi Hrncic, et al.. (2001). Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens. American Journal of Clinical Pathology. 116(1). 135–142. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact